Growth Vs. Vaccine

The J.P. Morgan View Growth versus virus now, vaccine versus virus later —an update on a conflict and a hope Cross-asset strategy: The dominant macro narrative of the past several weeks hasn’t changed much, and neither has the pattern of uneven advances across and within global markets. The reality of a booming economy versus the…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here